2018
Chiropractic Integrated Care Pathway for Low Back Pain in Veterans: Results of a Delphi Consensus Process
Lisi AJ, Salsbury SA, Hawk C, Vining RD, Wallace RB, Branson R, Long CR, Burgo-Black AL, Goertz CM. Chiropractic Integrated Care Pathway for Low Back Pain in Veterans: Results of a Delphi Consensus Process. Journal Of Manipulative And Physiological Therapeutics 2018, 41: 137-148. PMID: 29482827, PMCID: PMC6103526, DOI: 10.1016/j.jmpt.2017.10.001.Peer-Reviewed Original ResearchConceptsLow back painBack painIntegrated care pathwayCare pathwayChiropractic careSeed statementsVeterans Affairs health care facilitiesRAND/UCLA methodologyCommon mental health conditionsMental health comorbiditiesPatient-reported outcomesPrimary care providersAdverse event reportingMental health conditionsDelphi consensus processHealth care facilitiesConsensus processMental health providersMental health initiativesModified Delphi processMental health professionalsChiropractic managementHealth comorbiditiesCare algorithmClinical presentation
2015
Adverse Event Reporting and Quality Improvement in the Intensive Care Unit
Heavner JJ, Siner JM. Adverse Event Reporting and Quality Improvement in the Intensive Care Unit. Clinics In Chest Medicine 2015, 36: 461-467. PMID: 26304283, DOI: 10.1016/j.ccm.2015.05.005.Books
2013
Adverse Event Reporting in Cancer Clinical Trial Publications
Sivendran S, Latif A, McBride R, Stensland K, Wisnivesky J, Haines L, Oh W, Galsky M. Adverse Event Reporting in Cancer Clinical Trial Publications. Journal Of Clinical Oncology 2013, 32: 83-89. PMID: 24323037, DOI: 10.1200/jco.2013.52.2219.Peer-Reviewed Original ResearchConceptsConsolidated Standards of Reporting TrialsReports of adverse eventsAdverse eventsAdverse event reportingTrial publicationsEvent reportingCompleteness scoreOncology publicationsPublication of randomized trialsMedical decision-makingReview of citationsClinical trial publicationsRegression analysisControlled phase III trialReport adverse eventsConsolidated StandardsReporting TrialsMetastatic solid malignanciesPhase III trialsYear of publicationLinear regression analysisIII trialsSolid malignanciesPublication characteristicsRandomized trialsMitigating Adverse Event Reporting Bias in Spine Surgery
Auerbach JD, McGowan KB, Halevi M, Gerling MC, Sharan AD, Whang PG, Maislin G. Mitigating Adverse Event Reporting Bias in Spine Surgery. Journal Of Bone And Joint Surgery 2013, 95: 1450-1456. PMID: 23965694, DOI: 10.2106/jbjs.l.00251.Peer-Reviewed Original ResearchConceptsIndependent clinical events committeeClinical events committeeAdverse eventsClinical trialsLevels of severityInvestigational device exemption studyFuture clinical trialsAdverse event dataLumbar spinal fusionAdverse event reportingAdverse event reportsSpinal stenosisEvents committeeSafety profileSurgery StudyFusion groupInvestigator biasSpine surgerySpinal fusionSpine surgeonsSurgeryInvestigational deviceStudy sponsorEvent reportingFinancial interests
2011
A Novel Approach to Increase Residents' Involvement in Reporting Adverse Events
Scott DR, Weimer M, English C, Shaker L, Ward W, Choi D, Cedfeldt A, Girard D. A Novel Approach to Increase Residents' Involvement in Reporting Adverse Events. Academic Medicine 2011, 86: 742-746. PMID: 21512369, DOI: 10.1097/acm.0b013e318217e12a.Peer-Reviewed Original ResearchConceptsAdverse event reportingAdverse eventsPatient safetyResident involvementEducational campaignsAdverse event reportsQuality improvement initiatives
2008
A Randomized, Double-Blind, Placebo-Controlled Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients With Alzheimer's, Vascular, or Mixed Dementia
Rappaport S, Marcus R, Manos G, McQuade R, Oren D. A Randomized, Double-Blind, Placebo-Controlled Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients With Alzheimer's, Vascular, or Mixed Dementia. Journal Of The American Medical Directors Association 2008, 10: 21-27. PMID: 19111849, DOI: 10.1016/j.jamda.2008.06.006.Peer-Reviewed Original ResearchConceptsAgitation-Calmness Evaluation ScaleIM aripiprazoleIM placeboMixed dementiaIntramuscular aripiprazoleDoses 2 hoursIncidence of oversedationTreatment of agitationHealthcare facilitiesPreliminary efficacy analysisAdverse event reportingNegative Syndrome ScaleLong-term careAcute agitationEfficacy analysisTolerability studyPlaceboPEC scoresAripiprazoleGreater incidenceSyndrome ScaleGreater efficacyPatientsVital signsDementia
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply